# CCRM Houston – FDA Inspection, May 10, 2012

Source: https://www.keypedia.com/records/fda_inspections/ccrm-houston/45a3fa6e-52d3-4a3c-9bb7-6ccd00a34ef2
Source feed: FDA_Inspections

> FDA inspection 781326 of CCRM Houston, May 10, 2012. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 781326
- Company Name: CCRM Houston
- Inspection Date: 2012-05-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1284584 - 2025-09-16](https://www.keypedia.com/records/fda_inspections/ccrm-houston/d8c7667d-f124-4bf5-9e5c-ae1bb082bca0)
- [FDA Inspection 1191375 - 2022-11-08](https://www.keypedia.com/records/fda_inspections/ccrm-houston/caaf4ee2-591d-44b0-a74c-dc9f4835a3fb)
- FDA Inspection 1049725 - 2018-04-03
- FDA Inspection 877840 - 2014-05-06

Company: https://www.keypedia.com/companies/ccrm-houston/3f814604-5c07-41f9-a04c-4724cb469821

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d